Protez Pharmaceuticals
Protez Pharmaceuticals, Inc. develops antibiotics for the hospital market. Its product pipeline includes Protez, an antibiotic; PZ-601, a carbapenem antibiotic; The company’s products are used in the treatment of drug-resistant and life-threatening infections. Protez Pharmaceuticals, Inc. was founded in 2003 and recently acquired by Novartis. Protez is a standalone subsidiary of Novartis headquartered in Malvern, Pennsylvania
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
9
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Protez Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- WL
Weiping Li
Chemist · Science
EmailPhone - KE
Klaus Esser
Chief Business Officer, Co-founder · General Business & Management
EmailPhone
Showing 2 of 5 verified contacts
Top roles at Protez Pharmaceuticals
4 distinct titles indexed · top 4 shown.
- 1chemist
- 1chief business officer, co-founder
- 1scientist ii
- 1sff
Sign up to unlock all 5 contacts at Protez Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Protez Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.